Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation - discussion.

8 May 2021 (11:10 - 11:20)

Organised by:

4 More presentations in this session

Presentation thumbnail

Sarcoidosis: positron emission tomography (PET) is king.

Doctor S. Dorbala (Boston, US)

Presentation thumbnail

Sarcoidosis: CMR is king.

Doctor A. Patel (Charlottesville, US)

Presentation thumbnail

Amyloid: nuclear is king.

Doctor A. Gimelli (Pisa, IT)

Presentation thumbnail

Amyloid: CMR is king.

Professor M. Fontana (London, GB)

Access the full session

Session thumbnail

Cardiovascular magnetic resonance vs nuclear in amyloidosis and inflammation

The Event

EuroCMR 2021

8 May 2021 11:10 CET

You may be interested in

Webinar

Cardiac MR in the management of heart failure patients

21 March 2022

Congress Presentation

Correlation between invasive and non-invasive quantification of myocardial amyloid load in cardiac transthyretin amyloidosis

29 June 2021

Congress Presentation

Cardiac amyloid radionuclide imaging - discussion

11 December 2025

Congress Presentation

Utility of left ventricular strain analysis by cardiac magnetic resonance feature tracking in patients with amyloid cardiomyopathy

21 May 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources